Alimetry Secures CPT III Reimbursement Code for the Gastric Alimetry Test and Announces Positive Clinical Study Results
- : Alimetry Ltd
- : 12/02/2024
Alimetry, a gastrointestinal medtech and digital health start-up, announced today the creation of a new American Medical Association (AMA) Current Procedural Terminology (CPT) III code for Body Surface Gastric Mapping, which will describe its Gastric Alimetry test.
The new CPT III code highlights the growing recognition of Body Surface Gastric mapping and Gastric Alimetry as a significant advance in the diagnosis and management of chronic gastric conditions, including functional dyspepsia, gastroparesis, and chronic nausea and vomiting syndrome. Together, these disorders affect >10% of the US population.
CEO, Greg O’Grady, a Professor of Surgery and co-founder of Alimetry, said: “Obtaining a CPT III code is a key milestone for Alimetry. Gastric Alimetry is emerging as a next-generation test for patients suffering chronic gastric symptoms, with excellent early adoption in over 30 hospitals and clinics. The new AMA code will accelerate our mission to achieve widespread access for US patients suffering from these disabling disorders.”
The CPT III code comes on the back of Alimetry’s 3rd 510k clearance from the US Food and Drug Administration (FDA) in just 2 years for the Gastric Alimetry System. The latest FDA clearance introduced new features to aid in the diagnosis of gut hypersensitivity and common ‘Gut-Brain-Axis’ disorders, which are often linked to mental wellbeing. Chief Medical Officer Professor Chris Andrews stated: “Gastric symptoms can be complex, and are often a diagnostic challenge. Gastric Aimetry combines a wearable sensor with an App- based digital health profiling tool, providing an increasingly powerful feature set that can greatly simplify the diagnostic process. The cloud-based platform also enables us to rapidly learn and improve test performance based on banked data, with an increasing focus on applications in AI.”
In addition to the new CPT Code, Alimetry also announced positive clinical study results, published this month in the American Journal of Gastroenterology. In the study discussion, the authors concluded that “Gastric Alimetry identified 2.7x more specific patient categories than gastric emptying testing [a standard of care test], with limited overlap between each diagnostic modality, offering a valuable new option in the diagnostic work up of patients with chronic gastroduodenal symptoms”. In addition, Gastric Alimetry data was reported to show “improved correlation with symptoms and psychometrics” compared to existing clinical and research tools.
Gastric Alimetry is commercially available in the United States, the UK and New Zealand. The study article can be accessed in this hyperlink
About Gastric Alimetry
The Gastric Alimetry test measures gastric electrophysiology non-invasively in a clinical setting. Recordings are taken before and after a standard meal, while patients simultaneously log their symptoms into the Gastric Alimetry App. The system performs a high-resolution recording of digestive patterns from the skin surface and delivers clinical reports via the cloud to inform the diagnosis of gastric diseases and support personalized therapy. The Gastric Alimetry system is indicated as an aid to diagnosis of various gastric disorders, including functional dyspepsia, gastroparesis and chronic nausea and vomiting disorders, which affect >10% of the US population and impact billions of dollars in healthcare expenses.
About AMA CPT III Codes
AMA CPT III codes are temporary codes assigned to emerging medical technologies and procedures. These codes facilitate data collection and assessment, aiding in the validation and reimbursement of new services. Obtaining a CPT III code, such as for Alimetry’s Gastric Alimetry test, is a vital step towards recognizing its clinical relevance and supporting its integration into healthcare practices. The new CPT III code number is 0868T and it is effective from July 1, 2024.
Alimetry is a medtech and digital health start-up focused on improving the care of patients with chronic gastrointestinal symptoms. Spun out of the University of Auckland in 2019 from a centre of excellence in digestive diseases, the company was founded by Professor Gregory O’Grady (CEO) and Dr. Armen Gharibans (CTO), leveraging a decade of award-winning science. Alimetry is dedicated to advancing gastrointestinal health through innovative diagnostic solutions, aiming to enhance the quality of life for patients worldwide. For more information see www.alimetry.com
Hanie Yee, Chief Commercial Officer, Alimetry Hanie@alimetry.com
NZ +64 (0)21 651226 US +1 (657) 267 1082
- Alimetry CPT III Press Release 12th Feb 2024 (1)
- : Hanie Yee
- : Chief Commercial Officer, Alimetry
- : Hanie@alimetry.com
- : 64021651226
- : https://www.alimetry.com
- US Phone Number: +1 (657) 267 1082 | https://nz.linkedin.com/company/alimetry-ltd | @alimetry_ltd
Alimetry announces US FDA Clearance for Gastric Alimetry – A Breakthrough Non-Invasive Wearable Device for Gut Diagnostics
- : Alimetry Ltd
- : 15/06/2022
Auckland, New Zealand – Alimetry, a medical device and digital healthcare company, today announced it has received US Food and Drug Administration (FDA) clearance for Gastric Alimetry, a pioneering non-invasive medical device for aiding the diagnosis gastric disorders. Alimetry also announced today the launch of Alimetry Inc., a subsidiary based in Minneapolis, MN, that will market and distribute Gastric Alimetry in the United States.
“Gastric Alimetry is an industry-first and genuine breakthrough in gut diagnostics.” said CEO Greg O’Grady, a Professor of Surgery and co-founder of Alimetry. “Alimetry’s unique technology harnesses the power of stretchable electronics, wearables, digital health, and cloud-based analytics to deliver a completely non- invasive solution. We are thrilled to announce FDA’s clearance of Gastric Alimetry, making this new test available to millions of Americans suffering from chronic gastric symptoms”.
The Gastric Alimetry test is performed in a clinical setting. Recordings are taken before and after a meal, while patients simultaneously log their symptoms into the Gastric Alimetry App. The system performs a high-resolution recording of digestive patterns from the skin surface and delivers clinical reports via the cloud to inform the diagnosis of gastric diseases and support personalized therapy.
The system is indicated for common stomach disorders including nausea and vomiting, gastroparesis, and functional dyspepsia, affecting over 8% of the world’s population, and costing billions of dollars in healthcare expenses.1,2 The test is also currently available in the United Kingdom and New Zealand.
“Diagnosing gastric symptoms has been a deeply challenging clinical problem.” Dr. O’Grady said. “Existing tests are frequently unreliable and inconclusive, and patients may undergo months or even years of testing – often costly, invasive, or involving radiation – only to end in confusion and trial-and-error care. Gastric Alimetry is a game-changing tool that will bring improved clarity to field, enabling enhanced clinical outcomes, and safer, more accessible, and less-invasive care.”
Gastric Alimetry is the result of a decade of world-leading science and innovation by an interdisciplinary team of clinicians, engineers, designers and scientists.
“FDA clearance of Gastric Alimetry cements Alimetry’s path to leadership in gastrointestinal wearables and non-invasive diagnostics.” Dr. O’Grady said. “Alimetry has an outstanding pipeline of innovation and this is the first plank in a series of innovative new features and products that stand to transform care in disorders of gastrointestinal function”.
Gastric Alimetry will be available commercially from July 2022.
For more information on Gastric Alimetry visit www.alimetry.com
Alimetry was spun-out of the University of Auckland in 2019 from a centre of excellence in digestive diseases. The company was founded by Professor Gregory O’Grady, a gastrointestinal surgeon, and Dr. Armen Gharibans, on the background of a decade of award-winning science.
- Sperber AD, Bangdiwala SI, Drossman DA, Ghoshal UC, Simren M, Tack J, Whitehead WE, Dumitrascu DL, Fang X, Fukudo S, Kellow J. Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome Foundation global study. Gastroenterology. 2021 Jan 1;160(1):99-114.
- Lacy BE, Weiser KT, Kennedy AT, Crowell MD, Talley NJ. Functional dyspepsia: the economic impact to patients. Alimentary pharmacology & therapeutics. 2013 Jul;38(2):170-7.
- : Hanie Yee
- : Chief Operating Officer Alimetry Ltd
- : email@example.com
- : 6421651226
- : https://alimetry.com
- https://nz.linkedin.com/company/alimetry-ltd | @alimetry_ltd
- : Aotearoa 4 Assange
A group of lawyers, politicians, journalists and activists known as Aotearoa 4 Assange have written to PM Jacinda Ardern asking her to ‘stand strong’ with new Aussie PM Anthony Albanese, to ‘secure the freedom’ of Australian journalist Julian Assange. According to the letter Assange’s life is in peril and so are the ‘foundations of global democracy’.
A4A spokesperson Matt Ó Branáin says ‘the election of Albanese is a seismic shift’ for the campaign to free Assange, who is currently imprisoned in the UK and fighting extradition to the US. Unlike his predecessor Scott Morrison, Albanese is a member of the Bring Julian Assange Home Parliamentary Group consisting of at least 30 MPs. Albanese has reportedly said ‘enough is enough…I can’t see what’s served by keeping [Assange] incarcerated’.
Green MP and Human Rights lawyer Golriz Ghahraman tweeted ‘the threat to Wikileaks founder Julian Assange’s freedom is a threat to press freedom around the world.’
Assange has been detained in ‘solitary confinement’ for the last 3 years in the UK and a UN Special Rapporteur has said he is being ‘psychologically tortured.’ A letter from hundreds of doctors says he is likely to die soon if not freed.
The US charges ‘criminalise publishing leaked evidence of US state crimes’. International Human Rights groups, including Amnesty International and the Council of Europe’s Commissioner for Human Rights have said the case is a threat to global press freedom.
The letter argues that there is ‘no chance of justice’ if he is extradited to the US as Assange’s ‘legally privileged consultations with his lawyers were spied on’ and the Espionage Act ‘prohibits any public interest defence’.
Ó Branáin says ‘no one can credibly say justice has been seen in the UK extradition trial’. Amnesty International said the UK extradition trial was a ‘circus’. IBAHRI said ‘with this extradition trial, we are witnessing the serious undermining of due processes and the rule of law.’ Applications to monitor the trial from Amnesty International and Reporters Without Borders were declined. A4A’s letter says ‘this is a political case, and political intervention is required’.
UN Special Rapproteur on Torture Nils Melzer says if Assange is extradited to the US he would be detained in ‘conditions that amount to torture’. Ghahraman states that although the UK Magistrate Court has now ordered extradition to be signed ‘the Home Sec must decline’. ‘The UK has an obligation to avoid extradition to a place where he faces ill treatment and torture’. A4A called on Ardern to ‘make representations’ to Ms Patel not to sign the extradition order.
Rt. Hon Helen Clark said ‘you do wonder when the hatchet can be buried with Assange, and not buried in his head by the way?. . . ‘The real issue really is the activities they were exposing, not their actions of exposure.’
Ó Branáin says ‘Australia and New Zealand should call on our allies the US and UK, to end this perilous persecution of a South Pacific journalist, and bring Julian home.’
- : Matt Ó Branáin
- : National Co-ordinator of Aotearoa 4 Assange
- : firstname.lastname@example.org
- : 64204382863
- : https://www.a4a.nz/
- https://www.facebook.com/groups/a4assange | https://twitter.com/A4Assange | https://www.instagram.com/aotearoa4assange/ | https://www.youtube.com/channel/UC7Lgvm4ob5_kUS6NIaEXwvg
- : Aotearoa 4 Assange
- : 14/03/2022
Julian Assange Permitted to Marry in Belmarsh Prison
Wikileaks founder Julian Assange has been given permission to marry his fiancée Stella Morris in the maximum security Belmarsh prison in London on March 23rd. Stella is a member of his legal team and mother of his two young children. The couple had to fight for their right to marry, even bringing legal action against the UK Government.
Julian and Stella will be dressed by Vivienne Westwood. Julian will wear a kilt, honouring his Scottish ancestry. The couple are said to be very excited despite the severe restrictions imposed on the ceremony. They will be permitted only four guests and have been denied the request to marry in the prison’s Chapel, despite the fact that Julian regularly worships their.
Stella told the Daily Mail that the right to marry is ‘written into law’ in the UK. ‘Of course, the circumstances are not ideal but I am relieved that reason has prevailed and I hope there will be no further interference with our marriage. Julian is not charged with any crime in this country, he is not serving a sentence, his imprisonment serves no purpose at all other than to prolong and make his suffering worse. I hope the injustice of this situation is swiftly brought to an end so that we can enjoy marriage outside of the walls of Belmarsh when he is freed.’
Assange is being held in the notorious Belmarsh prison despite not being convicted of anything. He is awaiting the outcome of a US extradition request to face charges of ‘espionage’ for publishing evidence of war crimes and torture. Press freedom groups warn this unprecedented prosecution would criminalise fundamental journalistic practices.
Assange recently suffered a minor stroke, and doctors warn this will likely lead to a fatal stroke if his conditions are not improved quickly. He is detained in solitary confinement 23 hours per day, which fits the definition of torture under international law. The Australian Government has been criticised for ‘sitting on their hands’ over one of their citizens. The UN Special Rapporteur on Torture Nils Melzer said The Australian Government as ‘failed to support Julian Assange, and is complicit in his psychological torture.’
Helen Clark recently said ‘You do wonder when the hatchet can be buried with Assange? And not buried in his head by the way. But at some point, could people move on? I do think that the information that’s been disclosed by whistle-blowers down through the ages has been very important in broader publics getting to know what is really going on behind the scenes. And should people pay this kind of price for that? I don’t think so… The real issue really is the activities they were exposing, not their actions of exposure.’
Aoteroa 4 Assange is calling on the New Zealand Government to stand for Assange to protect human rights, the public’s right to know and peace.
- stella rainbow 2
- : https://twitter.com/i/status/1462562408749170689
- : Matt Ó Branáin
- : National Co-ordinator of Aotearoa 4 Assange
- : matt.o.branain@A4A.nz
- : 64204382863
- : http://a4a.nz
- https://www.facebook.com/groups/a4assange | https://twitter.com/A4Assange | https://www.instagram.com/aotearoa4assange/
- : Alimetry Limited
- : 02/03/2022
Alimetry, a digital healthcare and medical device start-up, announced today it has closed a NZ$16.3 Million financing round led by New Zealand largest venture capital investor Movac. Existing investor partners IP Group, Matū Karihi, and UniServices supported the round, with K1W1 also participating.
The company will use the funding to accelerate the international launch of its first product, a wearable diagnostic device called Gastric Alimetry. Gastric Alimetry uses a stretchable high-resolution sensor to non-invasively map digestive patterns, and delivers clinical reports via the cloud to inform the diagnosis and classification of gastric disorders.
“Chronic gastric symptoms are extremely common, yet many of our patients still suffer from repeated inconclusive tests, trial and error care, and confusion,” said CEO Greg O’Grady, a Professor of Surgery and co-founder of Alimetry. “Gastric Alimetry is on track to deliver breakthrough results in diagnosing gastric symptoms, enabling enhanced clinical outcomes and safer, more accessible, and less-invasive care.”
Gastric Alimetry targets prevalent stomach diseases including nausea and vomiting, gastroparesis, and functional dyspepsia, affecting over 8% of the world’s population and costing billions of dollars in healthcare expenses. The device is currently undergoing clinical trials in 5 countries, with results and further regulatory approvals expected during 2022. Alimetry will also use the new funding to expand its artificial intelligence capabilities and expand its product pipeline.
Lovina McMurchy, a General Partner at Movac who will join Alimetry’s Board, stated: “While Alimetry has only recently come out of stealth mode in New Zealand, the team has made an incredible amount of progress in bringing their product to market globally. They are already working with the top gastroenterology clinics in the world to trial the devices and they are in the approval process with the Federal Drug Administration in the US for full scale commercialization. This is a tremendous example of what our science ecosystem can produce at it’s very best.”
Gastric Alimetry has recently received numerous innovation and product design awards, including Gold from the Australian Good Design Awards, and a prestigious ‘Purple Pin’ at the New Zealand Best Design Awards. The Best Awards judges stated: “This is a tangible example of how New Zealand science, technology and design can work together to produce brilliant results.”
Alimetry was spun-out of the University of Auckland in 2019 from a centre of excellence in digestive diseases. The company was founded by Prof. Greg O’Grady and Dr. Armen Gharibans, on the background of a decade of award-winning science.
To learn more about Alimetry visit www.alimetry.com.
Movac is New Zealand’s largest and most experienced venture capital fund, supporting technology founders from early stage through to growth investing. Movac was the first institutional grade venture investor supported by both New Zealand Superannuation and Kiwi Wealth. It currently has $400m funds under management and invests across deep tech, software, hardware and healthtech.
About IP Group
IP Group is a leading intellectual property commercialisation company focused on evolving great ideas and cutting-edge research from its partner universities into world-changing businesses. The Group pioneers a unique approach to developing these ideas and the resulting businesses by providing access to business building expertise, capital, scientific insight, and supporting infrastructure. IP Group, which is listed on the London Stock Exchange (LSE: IPO), has a strong track record of success and, its portfolio comprises holdings in early stage to mature businesses across life sciences and technology. In Australia and New Zealand, IP Group works in close partnership with the Go8 Universities and the University of Auckland to identify ground-breaking technologies rooted in hard science, which have the most promising commercial potential. www.ipgroupanz.com
About University of Auckland Inventors’ Fund, managed by Auckland UniServices
The University of Auckland Inventors Fund is an evergreen, open-ended $20 million investment fund owned and managed by Auckland UniServices Limited, the commercial company for The University of Auckland. The Inventors’ Fund provides seed capital for ventures started out of the University of Auckland. www.uniservices.co.nz
About Matū Karihi Fund.
Matū is a venture capital fund investing in early-stage science and deep technology commercialisation from education and research institutions and the private sector. Karihi (nucleus) is Matū’s original pre-seed and seed-focused fund, working with start-ups at the earliest stages of their journey. As an open fund it raises capital over time and holds investments through to exit where possible, and therefore invests on a long timeframe. www.matu.co.nz
K1W1 Ltd is an investment company owned by Sir Stephen Tindall. It has invested over a total of $100M Seed and Venture capital into a large number of start-up and early stage businesses from Biotech, environmental technology, high tech, software and other high export potential businesses. The aim is, either directly or as a “fund of funds” to assist young entrepreneurs to grow New Zealand as a leader in the “knowledge economy” and to help create a culture of making New Zealand “cash flow positive” in international goods and services trade.
Attached files: Gastric Alimetry-11
- : https://youtu.be/Tw2sBEDQsPU
- : Hanie Yee
- : Chief Operating Officer
- : email@example.com
- : 6421651226
- : https://alimetry.com
- @alimetry_ltd | https://nz.linkedin.com/company/alimetry-ltd
Teams “Yadrava na Vanua” from Fiji and “Not Basic” from New Zealand win the Grand Prizes for Space Challenge
- : SpaceBase Limited
- : 18/02/2022
Christchurch—18 February 2022.
Yadrava na Vanua (Environment Watch) from Suva, Fiji won the Grand Prize today for the Space for Planet Earth Challenge.
Their project focused on integrating satellite data on land cover types across Fiji with ground truth measurements, and refining the carbon sequestration data with machine learning analysis of high resolution satellite images from Planet to generate international standard levels of measurements, reporting, and verification of carbon stocks.
Separately, “Not Basic” from Newlands College, Wellington, New Zealand, won the Grand Prize at the High School level. Their work featured using machine learning analysis of satellite data to predict the conditions leading to coral bleaching as detected within the Allen Coral Atlas with Planet satellite data.
Six teams from New Zealand, Australia, and Fiji competed in demo sessions with a panel of judges, then a Pitch presentation to a live online audience. The winners are awarded cash prizes of $30,000 and $10,000 each, satellite data from company Planet, and mentorship from SpaceBase. Additionally the High School team will receive scholarships from the US Based MMAARS Academy to attend their Level 1 Virtual Mars Programme.
“The presentations that I’ve seen were so amazing…and I was blown away by the ideas and the ability that they’ve shown…Planet is so proud to be part of this competition,” Dr. Tanya Harrison, Director of Strategic Innovation for Planet and a Finals Judge for the competition, said at the event.
The winners were selected by judges from Planet, the U.S. Embassy to New Zealand, Pacific GIS and Remote Sensing Council, Rocket Lab, Callaghan Innovation, ChristchurchNZ, Callaghan Innovation, and Consegna.cloud.
The awards were presented by the NZ Space Agency and the U.S. Embassy.
“I’ve been extremely impressed with the sophistication of the solutions that have been developed, by the approach of looking for different data sources to incorporate into those solutions, to reaching out to other organisations, establishing partnerships to make this more effective, and the quality of the presentations,” said Dimitri Geidelberg, Principal Advisor to the Agency.
The Challenge was the brainchild of SpaceBase founders who leverage incentive prizes and space technologies to catalyse innovation while solving tough problems in the region. “Already, we see the Challenge as pushing the teams to accelerate their research and create opportunities they may not otherwise have been able to realise.” said Emeline Paat-Dahlstrom, CEO of SpaceBase. “We think this is only the beginning for these climate change focused innovations, and we hope to continue to support these teams in their progress over the coming months and years.”
For more information about the Challenge and the Winners, go to spaceforearth.org
The Challenge is made possible by a partnership between SpaceBase Limited and Planet. Sponsors include the U.S. Embassy in New Zealand, K1W1, NZ Space Agency, ChristchurchNZ, Consegna.cloud, Clare Foundation, Greenlight Ventures, Namaste Foundation, Engineering Dreams, MMAARS Academy, and Christchurch City Council.
SpaceBase Limited is a New Zealand based education and consulting social enterprise, whose mission is to democratise access to space for everyone. SpaceBase is creating equal opportunity to leverage space technologies to solve problems on Earth, by catalysing space ecosystems in developing and emerging countries, starting in New Zealand. Since its incorporation in 2017, it has collaborated with economic development agencies, local governments, and advocacy groups to deliver over 100 educational presentations and workshops; two national space and aerospace competitions, as well as helping birth space communities and organisations locally and globally. SpaceBase created a platform for the NZ Aerospace Directory and a free course, Catalysing a Space Industry in Your Region, for anyone interested in creating a local space industry. SpaceBase is also the NZ Ambassador for the International Space University.
- Promo Video Thumbnail
- : Emeline Dulce M Paat-Dahlstrom
- : CEO
- : firstname.lastname@example.org
- : 0224021936
- : https://spacebase.co
- https://twitter.com/SpaceBaseNZ + https://www.facebook.com/groups/SpaceBaseNZ + https://www.linkedin.com/company/13643678/admin/
Alimetry Leaves Stealth Mode to Announce CE Mark on New Wearable Medical Device for Gastric Diseases and Investment
- : Alimetry Ltd
- : 16/04/2021
Alimetry, a digital healthcare and diagnostic devices start-up, announced today that it has achieved CE Mark for its first product, a pioneering medical device for enabling diagnosis of gastric diseases.
The new wearable product, called Gastric Alimetry, is positioned to transform the diagnostic pathway for millions of patients worldwide suffering from diseases such as functional dyspepsia, gastroparesis and chronic nausea and vomiting. Gastric symptoms are extremely prevalent and impart a vast burden, affecting around 10% of the global population. The Gastric Alimetry device collects data by non-invasively sensing the activity of the stomach from the body surface. The data is sent to the cloud for analysis, and is used by clinicians to determine the causes of gastric symptoms and direct treatment.
Co-Founder and CEO Professor Greg O’Grady said “As clinicians, we lack the tools we need to reliably diagnose gastric disorders. This contributes greatly to the frustration and suffering of our patients. I was driven to this cause by seeing too many patients go through laborious, invasive and expensive rounds of repeat diagnostic testing, only to end up with inconclusive results and confusion. We invented Gastric Alimetry to help address this need. I am immensely proud of our hard-working team who have delivered an incredibly creative solution with outstanding potential to impact patient care.”
In addition to successfully achieving CE mark for the Gastric Alimetry product, enabling the company to start commercializing the medical device in European countries, Alimetry also announced today that it had achieved the ISO 13485 international quality management system accreditation. As it grows global operations, the company has enhanced its executive team with new appointments. Hanie Yee joined the company as Chief Operating Officer, from her previous role as Clinical Business Lead at Fisher & Paykel Healthcare, and Professor Chris Andrews, a leading gastroenterologist from Canada, has joined Alimetry as Chief Medical Officer.
Alimetry has been the culmination of over a decade of award-winning scientific research out of The University of Auckland, backed by scientific grants from the New Zealand Health Research Council and the US National Institutes of Health, followed by Callaghan Innovation funding. To support the next phase of growth, the company completed its first institutional investment round, led by IP Group, a leading international intellectual property commercialisation company. The investment round was supported by UniServices Ltd (via the University of Auckland’s Inventors’ Fund), and Matū, a New Zealand early-stage science and deep-tech venture capital fund. The capital raised by Alimetry will be used to advance the company’s clinical trials, enter the market, and progress regulatory approval in the United States.
The Managing Director of IP Group Australia, Dr Michael Molinari, said “We are excited to be working with Professor O’Grady and the world-class team at Alimetry to provide a step change in the quality of life for millions of patients with gastric disorders. This technology, at the intersection of multiple exponentially growing fields such as wearable medical devices, digital health, and machine-learning assisted diagnostics, is another great example of the breakthrough innovations coming from our partners at the University of Auckland”.
Alimetry was founded in 2019 as a spin-out company from the University of Auckland’s Bioengineering Institute and Faculty of Medical and Health Sciences. The company was founded on a background of world-leading science in gastrointestinal diseases. Alimetry is dedicated to improving the lives of patients by delivering innovative medical solutions to advance GI diagnostics and enable targeted therapies. www.alimetry.com
About IP Group
IP Group is a leading intellectual property commercialisation company focused on evolving great ideas from its partner universities into world-changing businesses. The Group pioneered a unique approach to developing these ideas and the resulting businesses by providing access to business building expertise, capital, scientific insight, and the supporting infrastructure. In Australia and New Zealand, IP Group works in close partnership with the Go8 Universities and the University of Auckland to identify ground-breaking technologies, rooted in hard science, which have the most promising commercial potential. IP Group, which is listed on the Main Market of the London Stock Exchange under the symbol IPO, has a strong track record of success and its portfolio comprises holdings in early stage to mature businesses across life sciences and technology.
Discover more at www.ipgroupanz.com
About The University of Auckland Inventors’ Fund. The University of Auckland Inventors Fund is an evergreen, open-ended $20 million investment fund owned and managed by Auckland UniServices Limited, the commercial company for The University of Auckland. The Inventors’ Fund provides seed-capital for ventures started out of the University of Auckland. www.uniservices.co.nz
About Matū Fund. Matū is a venture capital fund investing in early-stage science and deep technology commercialisation from education and research institutions and the private sector. As an open and evergreen fund, Matū takes a long-term investment view and is aimed at turning ground-breaking ideas into globally focused, IP-rich companies. Matū provides intelligent capital with active governance, executive management, operational support, and mentorship for founding and executive teams. www.matu.co.nz
Released images (png format):
Hanie Yee, Chief Operating Officer
M: +64 (0) 21 651 226
- : Hanie Yee
- : Chief Operating Officer
- : email@example.com
- : 6421651226
- : https://alimetry.com/
PIONEERING DECENTRALISED SECURE MESSAGING PLATFORM MANYONE ANNOUNCES STRATEGIC RELATIONSHIP WITH UNIVERSITY COLLEGE LONDON CENTRE BLOCKCHAIN TECHNOLOGY
- : Manyone Inc.
- : 25/02/2021
Vancouver, Canada – February 25th, 2021 – Manyone Inc., a pioneering technology venture in decentralization and digital identity, is delighted to announce that it has entered into a new strategic relationship with the globally renowned University College London (UCL) Centre Blockchain Technology (CBT).
This partnership will support research conducted by UCL CBT’s Senior Research Associate, Dr Geoffrey Goodell, to explore and evaluate end-user technology systems, infrastructure, business imperatives, and regulatory policy to support the privacy, dignity, and market power of individual persons in the emerging digital economy. The research is aimed at identifying the requirements and approaches for systems whose features specifically support the advancement of truly consensual trust relationships, the empowerment of local communities, and the public interest.
Vancouver-based Manyone believes in empowering solutions and technologies with the potential to produce a new, distributed internet where everyone can feel safe, secure and in control of their digital identity.
Dr Paolo Tasca, Founder and Executive Director of the UCL Centre for Blockchain Technologies, notes that, “On behalf of UCL and the Centre for Blockchain Technologies, I am delighted to begin our new partnership with international industry partners Peer Social Foundation and Manyone. We are grateful for their support and recognition of the impactful research being done to meet our shared ambitions. Thanks to their generosity we will continue our proud tradition of enabling academic research with real-world application.”
Michael Cholod CEO at Manyone and Executive Director of The Peer Social Foundation comments, “As a dedicated group of decentralists, our teams look to find ways to free communication from manipulation and control by protecting individual, business or governmental digital identities. Part of that mission is to work with the most respected and knowledgeable people in the field. The team at UCL represent some of the best thinkers in the area and we’re honoured to work with them.”
Dr Geoffrey Goodell, Senior Research Associate at UCL Centre for Blockchain Technologies, specifically ads that, “The funding from The Peer Social Foundation and Manyone will provide vital resource to explore and evaluate user-controlled identity management, decentralised social networks, and tokenisation as vehicle for authorisation without identification. Our partnership will support the advancement of trusted relationships in the digital economy, the empowerment of local communities for the benefit of public interest. I am excited to deepen our collaboration and share our insights.”
Manyone, with offices in Vancouver, Canada and Stockholm, Sweden are looking to launch the first decentralised secure messaging solution by Mid-2021.
Manyone is a pioneering technology venture that aims to deliver private secure networks and private digital identities, to increase personal and enterprise productivity and digital security. Manyone actively works with The Peer Social Foundation on education and research into topics of interest to consumers and enterprise. The Peer Social Foundation and Manyone believe in empowering a distributed internet where everyone can feel in control of their digital identity. They do this by delivering a self-sovereign digital identity and decentralized communication and sharing platform for enterprise and consumers. A critical component of this is to work beside and support vital education, R&D and the open-source community to connect people, business.
- : Michael Cholod
- : Chief Executive Decentralist
- : firstname.lastname@example.org
- : 16048361112
- : https://manyone.one
- : Paste & Publish
- : 24/02/2021
Paste & Publish, a New Zealand based content marketing agency announced today that they are setting aside 5% of revenue to provide pro bono work to selected environmental projects that wouldn’t otherwise be able to afford professional help.
Paste & Publish Founder, Callum Armstrong, says that this commitment is important because our natural world is in a state of crisis.
“I believe that it is our responsibility as business owners to help create the future we want to leave for our children.
There’s no silver bullet in the fight against climate change, but every little bit of help makes a difference,” says Armstrong.
“That’s why we have built philanthropy into our business model – to ensure that as we grow, so does our positive impact on the planet.”
The first project that will receive support from their 5% pledge is The Reforestation Fund. This fund, which is set to launch later in the year, provides sustainable and ethical brands with a way to help the environment as part of their offering.
Companies who support The Reforestation Fund donate a small amount from every sale on selected products, and are allowed to display the fund’s endorsement in return. Money raised is used to help community projects that plant native forests and support groups that look after our native plants and wildlife.
The Reforestation Fund co-founder, Anna Wentsch, says that people are looking for ways to support the environment, and that the services provided by Paste & Publish will empower TRF to make it easy for people to do just that.
“We are extremely grateful for the support that Paste & Publish is providing by designing our brand identity and rebuilding our website.
This will set up the foundations for us to connect people and companies with our natural world,” says Wentsch.
Armstrong says that companies who design philanthropy into their everyday operations experience a wide range of benefits. They often see higher rates of customer retention and trust, happier staff who know they are doing good in the world, increased sales and less reliance on price based competition.
About Paste & Publish
Based in the Bay of Plenty, New Zealand, Paste & Publish provides content marketing services to companies that want to grow. They help brands to attract their ideal customers by creating high value strategic content, and using sales funnels to convert them into paying clients. To find out more, visit www.pasteandpublish.com.
- : Callum Armstrong
- : Managing Director
- : email@example.com
- : 642102671022
- : https://www.pasteandpublish.com
- https://www.facebook.com/pasteandpublish | https://www.instagram.com/pasteandpublish | https://www.linkedin.com/company/71003381
- : Inka Bands
Founder of ‘Inka Bands™’ in Auckland recently launched a new online store featuring stylish exercise accessories to meet rising demand for at-home fitness gear
Auckland, New Zealand — Oct. 12th, 2020 — The COVID-19 pandemic has presented a mountain of challenges to entrepreneurs everywhere.
But any ambitious visionary knows in challenges there are often opportunities.
Many entrepreneurs have used the pandemic as a chance to rebrand, pivot, and activate new ideas for these new and unusual times.
For Auckland entrepreneur Wayne Bowater, the pandemic presented him with an opportunity to launch a new brand to meet a new need.
Bowater is the managing director of McKenzie Group, a global distributor of quality health and wellness products sourced in New Zealand, and Mckenzie Distribution for its New Zealand distribution requirements. Recognizing a spike in at-home fitness due to the pandemic, he launched Inka Bands™ to introduce stylish and fashionable wrist weights and ankle weights for fitness enthusiasts in New Zealand and Australia.
“Though many entrepreneurs have taken a big hit during the pandemic, some of us have tried to stay alive by looking for new opportunities during the coronavirus lockdown,” Bowater said. “With so many people now working out at home, I came up with a fun new idea to power their workouts with great-looking hands-free weights to go along with their great-looking workout gear.”
The name INKA is a nod to a slang term referring to “the best friend you could ever ask for.” Inka Bands offer a comfortable way to add resistance to a home workout with attractive wrist and ankle weights manufactured from the highest quality fitness materials. Every Inka Band is waterproof. They come in a range of contemporary colours.
“Whether exercising along with a virtual workout at home, running, biking, hiking, rehab, yoga outdoors, or heading back to the gym for a Pilates session, we’ve got you covered with Inka Bands,” Bowater said. “Our beautiful weighted bands are perfect for boosting the muscle-building and fat-burning power of any workout. Best of all, you can wear them down to the cafe afterwards due to their stylish design sensibility.”
Learn more about Inka Bands and shop online at https://inkabands.co.nz.
- Inka Bands model pic
- : Wayne Bowater
- : Director
- : firstname.lastname@example.org
- : 094485830
- : https://inkabands.co.nz